SQZ Biotechnologies Company
SQZB
$0.04
$0.01242.86%
OTC PK
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -17.48% | -1.90% | |||
| Gross Profit | 16.31% | 3.28% | |||
| SG&A Expenses | 23.20% | -13.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.76% | -5.31% | |||
| Operating Income | 5.79% | 6.28% | |||
| Income Before Tax | -40.96% | 5.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -40.96% | 5.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -40.96% | 5.18% | |||
| EBIT | 5.79% | 6.28% | |||
| EBITDA | 8.40% | 6.25% | |||
| EPS Basic | -40.98% | 5.19% | |||
| Normalized Basic EPS | 4.84% | 5.18% | |||
| EPS Diluted | -40.98% | 5.19% | |||
| Normalized Diluted EPS | 4.84% | 5.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||